Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BASOSYN PLUS is a multi-ingredient nutraceutical food supplement developed by Homeosyn Italia, formulated as oral tablets. It is designed to restore acid-alkaline balance in the digestive system and address gastrointestinal symptoms such as hyperacidity, bloating, flatulence, and meteorism. The product contains a combination of minerals (calcium, magnesium, and potassium), vegetable charcoal (carbone vegetale), and botanical extracts including green anise (*Pimpinella anisum*), fennel (*Foeniculum vulgare*), and asparagus (*Asparagus racemosus*), along with spirulina algae powder. Its mechanism of action involves buffering fermentation processes, promoting regular gastrointestinal motility and gas elimination through the carminative properties of anise and fennel, and supporting the drainage of body fluids via asparagus root extract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BASOSYN PLUS.